Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page
- Check4 days agoChange DetectedThe page now includes a notice about heavy traffic affecting NLM-NCBI services and mentions Sahlgrenska University Hospital, while the reference to Vastra Gotaland Region has been removed.SummaryDifference3%
- Check11 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check25 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check32 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.4%
- Check40 days agoChange DetectedThe Vastra Gotaland Region has been added, while Sahlgrenska University Hospital in Sweden has been removed.SummaryDifference1%
- Check61 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.